CD44 and glioblastoma: Expression of CD44 promotes SRC activation, a physiological proto-oncogene, a protein–tyrosine kinase that plays crucial roles in signaling pathways related to cell growth, division, migration and survival [61] leading to epithelial–mesenchymal transition in GBM cells [62].